References
- Miller RG, Bouchard JP, Duquette P et al. Clinical trials of riluzole in patients with ALS. Neurology 1996; 47(Suppl 2): S86–S92.
- Miller RG, Moore D, Young LA et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 1996; 47: 1383–1388.
- Miller RG, Moore DH, Gelinas DF et al. Phase III random- ized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843–848.
- Andres PL, Skerry LM, Thornell B, Portney LG, Finison LJ, Munsat TL. A comparison of three measures of disease pro- gression in ALS. J Neurol Sci 1996; 139(Suppl): 64–70.
- Hoagland RJ, Mendoza M, Armon C et al. Reliability of maximum voluntary isometric contraction testing in a multi- center study of patients with amyotrophic lateral sclerosis (Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS study group). Muscle Nerve 1997; 20: 691–695.